![Ivan Møller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivan Møller
Geschäftsführer bei
ZEALAND PHARMA A/S
Vermögen: 3 Mio $ am 30.06.2026
Profil
Ivan M.
Møller currently works at Zealand Pharma A, as Chief Operating Officer & Executive Vice President.
Mr. Møller also formerly worked at PolyPeptide Laboratories A, as Head-Production from 2002 to 2003, Novartis AG, as Global Head-Operations Management from 2017 to 2018, and Novartis Corp., as Vice President & Head-External Supply Organization from 2017 to 2018.
Mr. Møller received his graduate degree from Technical University of Denmark and Masters Business Admin degree in 2005 from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZEALAND PHARMA A/S 0.11% | 31.12.2025 | 78’587 ( 0.11% ) | 3 Mio $ | 30.06.2026 |
Aktive Positionen von Ivan Møller
| Unternehmen | Position | Beginn |
|---|---|---|
| ZEALAND PHARMA A/S | Geschäftsführer | 01.03.2018 |
Ehemalige bekannte Positionen von Ivan Møller
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.01.2018 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01.01.2018 |
PolyPeptide Laboratories A/S
 PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Ivan Møller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyPeptide Laboratories A/S
PolyPeptide Laboratories A/S Chemicals: SpecialtyProcess Industries Manufactures polypeptides and custom peptide synthesis | Process Industries |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wählen Sie MarketScreener 
